Screener
AngioDynamics ANGO EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: AngioDynamics’s 10-Q, filed October 8, 2026.
- Filed
- Oct 8, 2026, 12:56 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q3 2026
- Accession
- 0001628280-26-065423
FAQ
- What is AngioDynamics's EPS (diluted)?
- AngioDynamics (ANGO) reported EPS (diluted) of -$0.17 in Q2 2026.
- How has AngioDynamics's EPS (diluted) changed year-over-year?
- AngioDynamics's EPS (diluted) increased by 34.6% year-over-year, from -$0.26 to -$0.17.
- What is the long-term trend for AngioDynamics's EPS (diluted)?
- Over 4 years (2022 to 2026), AngioDynamics's EPS (diluted) has grown at a 6.4% compound annual growth rate (CAGR), from -$0.68 to -$0.87.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about AngioDynamics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude